Webinar | Artificial Intelligence| July 07, 2020

WEBINAR: Do More, Perform Better: Delivering Clinical Quality through Advanced Radiology and Artificial Intelligence

Riverain sponsored webinar is now available on-demand

Riverain sponsored webinar is now available on-demand

Every day, radiology practices are challenged to do more and perform better to improve patient care. An AI-driven workflow — powered by machine learning and advanced modeling — supports radiologists in this effort, helping to reduce turnaround times, improve clinical quality, and focus on patient treatment and outcomes.

As part of the LucidHealth RadAssist workflow, the ClearRead suite from Riverain Technologies allows radiologists to improve a clinician’s ability to accurately and efficiently detect disease in thoracic CT and X-ray images and more successfully address the challenges of early detection of lung disease.

This webinar will demonstrate the integration of AI into the LucidHealth radiology workflow, where you’ll learn the best practices of combining leading radiologist expertise with cutting edge AI, as well as the outcomes in quality and efficiency that solutions like Riverain ClearRead can provide.

 

Learning Objectives:

At the end of this webinar, attendees will see how a best-in-class radiology workflow – partnered with best-of-breed clinical AI — can help deliver:

  • Industry-leading turnaround times
  • Improved detection rates that enhance clinical quality
  • Improved work-life balance for radiologists

 

The webinar originally aired on July 15 at 2 ET and is now available on-demand.

 

View the webinar on-demand.

 

Speakers:

Peter Lafferty, M.D.

Chief of Physician Integration, LucidHealth

Peter Lafferty, M.D., a partner with Riverside Radiology and Interventional Associates for 20 years, holds an undergraduate degree from Duke University, graduated with honors from the University of Cincinnati College of Medicine, and completed his radiology residency at the University of Minnesota Hospital. As an integral member of the LucidHealth board, Lafferty brings an innovative approach to patient-centered solutions. Since joining the group in 2000, Lafferty has been an instrumental influence in the development of RadAssist. This proprietary software manages diagnostic images across multiple platforms, enhances the work processes for the physician while increasing the efficiency and quality of care for the patient.

Steve Worrell, CEO
Riverain Technologies

Steve Worrell became CEO of Riverain Technology in 2013 and is responsible for Riverain’s strategic direction and operational execution. He has over 30 years of experience in engineering, developing, and commercializing AI solutions for breast and lung cancer with multiple publications and patents. Along with technologies, his expertise ranges across regulatory, sales and marketing.

 

Company Profiles:

About LucidHealth

LucidHealth is a technology-enabled radiology services company providing best-in-class quality imaging care nationwide. Our physician-led partnerships, built on an innovative technology platform, create strategic value for radiology practices. Our proprietary software products, RadAssist, LucidView and LucidConnect, utilize a unified radiology workflow that directs imaging studies to the appropriate subspecialized radiologist and allow multidisciplinary collaboration. Our products enable real-time access to comparative studies across disparate hospitals and health systems, afford on-the-spot access to full quality images and provide a host of imaging data analytics that increase productivity, decrease turnaround times, and enhance patient care. For more information, please visit lucidhealth.com.

 

About Riverain Technologies

Dedicated to the early detection of lung disease, Riverain believes the opportunities for machine learning and software solutions in healthcare are at an unprecedented level. Never before has the opportunity to ‘do more with less’ been so great. We believe that these software tools incorporate an increasing degree of intelligence that will facilitate decision making, which leads to greater efficiency and effectiveness in patient outcomes. Riverain Technologies is excited to be part of the advances in machine learning and scalability of technology that will bring efficiency and accuracy to physicians and, ultimately, improved patient care. For more information, please visit riveraintech.com.

 

Resources:

lucidhealth.com

riveraintech.com

 

View the webinar on-demand.

 

Related Content

#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
April 15, 2021 — Siemens Healthineers AG an
A doctor reading #CXR scans using #SenseCare-Chest #DR Pro #diagnostic #software.

A doctor reading CXR scans using SenseCare-Chest DR Pro diagnostic software.

News | Artificial Intelligence | April 14, 2021
April 14, 2021 — SenseTime, a world-leading...
The U.S. Food and Drug Administration (#FDA) authorized marketing of #Medtronic's #GIGenius, the first device that uses #artificialintelligence (#AI) based on #machinelearning to assist #clinicians in detecting #lesions (such as #polyps or suspected tumors) in the #colon in real time during a c#olonoscopy.

The GI Genius intelligent endoscopy module works in real-time, automatically identifying and marking (with a green box) abnormalities consistent with colorectal polyps, including small flat polyps.

News | Artificial Intelligence | April 12, 2021
Futuristic campus design of Siemens Healthineers in Bengaluru, India.

Futuristic campus design of Siemens Healthineers in Bengaluru, India.

News | Radiology Business | April 08, 2021
April 8, 2021 — Siemens Healthineers announced t
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage F
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
April 7, 2021 — Vysioneer, a leader in a...